Figure 1 Median coverage and distribution by

Slides:

Advertisements

Similar presentations

Tessa Wardlaw UNICEF Headquarters, New York The Countdown Report: Part I.

Advertisements

MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop MICS4 in the Context of Global Commitments and Reporting Needs.

HIV/AIDS Webinar Statistics and Monitoring Tessa Wardlaw Statistics & Monitoring Section/Policy & Practice 20 October 2010.

Preparation the Multiple Indicator Cluster Survey Presented By: Kyaw Nan Da Myanmar.

Multiple Indicator Cluster Surveys (MICS) Contribution of MICS4 to Monitoring of National and International Commitments Sarah Ahmad Mirza 7 th December.

Progress and priorities for reproductive, maternal, newborn, and child health in Kenya: a Countdown to 2015 country case study Emily C Keats, PhD, Anthony.

Charts included in the Progress Report on MDGs

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Enteroids can model transport physiology

Figure 4 Activation of clopidogrel via cytochrome P450

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Injection of mesenchymal stem cells in perianal fistulas

Figure 1 Patients cured of HCV infection

Figure 4 Simple perianal fistula

Figure 1 Worldwide incidence of CCA

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 The microbiome–gut–brain axis

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Achieving maternal and child health gains in Afghanistan: a Countdown to 2015 country case study Nadia Akseer, MSc, Ahmad S Salehi, MSc, S M Moazzem.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Biosimilar development process

Figure 2 Effect of PPIs on gastric physiology

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Suggested biopsy-avoiding diagnostic pathway for coeliac disease Figure 1 | Suggested biopsy-avoiding diagnostic pathway for coeliac disease.

Figure 6 Combination therapy for HCC

Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 1 Definition and concept of ACLF

Figure 1 Host range of hepatitis E virus

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Volume 376, Issue 9743, (September 2010)

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 7 Example colonic high-resolution manometry

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Environmental factors contributing to IBD pathogenesis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Tropical sprue and PI-IBS

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 13C-octanoic acid gastric emptying breath test

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Figure 5 Chrononutrition in the liver

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Possible therapeutic targets to decrease hepatic steatosis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Progress and priorities for reproductive, maternal, newborn, and child health in Kenya: a Countdown to 2015 country case study Emily C Keats, PhD, Anthony.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Assessment of colonic transit time with radiopaque markers

Figure 5 Systems biological model of IBS

Figure 4 Local species pools that contribute to the

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Distribution of markers of active HBV infection

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Lifelong influences on the gut microbiome from

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Government of National Unity & Government of Southern Sudan

An Overview of the Programme.

Figure 1 The spread of colorectal cancer metastases

Training module on anthropometric data quality

Average national (bars) and state-level (dots) coverage of key nutrition actions (counselling, growth monitoring and food supplements) typically not included.

Presentation transcript:

Figure 1 Median coverage and distribution by country of selected nutrition sensitive and specific interventions Figure 1 | Median coverage and distribution by country of selected nutrition sensitive and specific interventions. Data based on analysis of Multiple Indicator Cluster Surveys and WHO and UNICEF joint monitoring programme for Water Quality and Sanitation. Adapted from Countdown to 2015, A decade of tracking progress for maternal, newborn and child survival: The 2015 Report (2015) (http://www.countdown2015mnch.org/documents/2015Report/Countdown_to_2015_final_report.pdf) Adapted from Countdown to 2015, A decade of tracking progress for maternal, newborn and child survival: The 2015 Report (2015) (http://www.countdown2015mnch.org/documents/2015Report/ Countdown_to_2015_final_report.pdf) Bhutta, Z. A. (2016) How will the next ‘Decade of Nutrition’ be different from the past one? Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2016.102